“…Endothelial cells are then incited on releasing even more chemokines and stimulating factors, in a positive feedback of proinflammatory response.³⁰ This role of proinflammatory protein release, triggered by SARS-CoV-2, may be exacerbated, which would be classically called "the cytokine storm".⁵¹ This typical immunological pattern, found among patients with COVID-19, is currently correlated with the evolution of the disease to more severe stages.⁵¹ The "cytokine storm" is associated to the pathophysiology of the pneumonia and the Acute Respiratory Distress Syndrome (ARDS), on SARS-CoV-2 positive patients.⁵¹ In the heart, inflammation plays a critical role on CVDs, like acute coronary events, left ventricular remodeling and heart failure.⁵² Thus, the cytokine storm must raise attention to the cardiovascular consequences in COVID-19, since its cardiac deployments are already described.⁵³ In this line, autopsies performed on COVID-19 deceased individuals have shown infiltration of interstitial mononuclear inflammatory cells on the myocardium,⁵³ corroborating that the cytokine storm may lead to cardiac outcomes, in which myocarditis could be one of these possible consequences.³ Furthermore, lymphopenia was also documented on COVID-19 patients, specially associated to low levels of CD4+ and CD8+ T cells, despite the late high levels of antiviral factors interferons (IFN-γ), which are secreted, mainly, by CD4+ T cells.²⁸ Lymphopenia is reversed by Tocilizumab, the anti-IL-6 antibody.⁵⁴ This kind of immune pattern is usually correlated with the evolution of the disease and associated with more severe cases when compared to moderate ones.⁵⁵ Studies already demonstrated that white blood cells count can be excellent predictor of coronary heart disease, as well as heart failure worst prognosis.⁵² One of the first works to demonstrate the association of lymphopenia and heart failure was the work of Hurdle, Gyde, & Willoughby in 1966. 56 The authors reported an association between the heart failure patients and the 'cold' controls in respect of lymphopenia, eosinopenia, and cortisol levels.⁵⁶ In agreement with this data, a previous study have associate lymphopenia with worse outcomes in patients with heart failure, chronic ischemic heart disease and acute coronary syndromes.⁵⁷ Also, the lymphopenia was proposed a key prognostic marker in heart failure. In this line it was demonstrated that lymphocyte count was inversely associated with survival at 1, 2 and 3 years after adjusting for clinical, laboratory, and pharmacological variables.⁵⁸ As described above, within the cytokines, IL-1B plays an important role in the SARS-CoV-2 physiopathology.…”